CHINA BULLETIN: Weak Economic Signals All Around
In this week’s issue weak signals in trade and inflation, and LinkedIn links out. On a scale of 1 to 100, we give the week a 40 for offshore-listed China stocks.
CHINA BULLETIN: No New Year Cheer for Exports
In this week’s issue exports tank and steel output slides, while Didi drives back into China app stores. On a scale of 1 to 10, we give the week a 6 for offshore-listed China stocks.
FAST NEWS: CanSino Spends $21 Million on Share Buyback
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) said Friday it bought back about 670,000 of its Shanghai-listed A-shares for 147 million yuan ($20.8 million) as of Nov. 30, accounting for…
FAST NEWS: CanSino Holds Low Revenue Hopes for Inhaled Covid Booster
The latest: CanSino Biologics Inc. (6185.HK; 688185.SH) said Thursday its inhaled recombinant Covid-19 vaccine booster recently began to be administered in 13 cities in Shanghai and Jiangsu province. But it…
AIM Puts mRNA Covid Vaccine in Investor Crosshairs With New IPO Attempt
Vaccine maker’s previous IPO bids on Shenzhen’s ChiNext board and in Hong Kong failed, but it is soldiering ahead with a new attempt in Hong Kong Key takeaways: Vaccine maker AIM…
FAST NEWS: CanSino’s Covid mRNA Vaccine Approved for Clinical Trials in China
The latest: A new Covid-19 mRNA vaccine developed by CanSino Biologics Inc. (6185.HK) has been approved by China’s National Medical Products Administration to begin clinical trials in the country, the…
FAST NEWS: CanSino’s Covid Vaccine Approved for Boosters in China
The latest: CanSino Biologics Inc. (6185.HK) announced on Sunday that its recombinant novel coronavirus vaccine Convidecia has been approved for use in China in a “mixed” booster vaccination program to…
Recent Articles
RELATED ARTICLES
-
As solar construction in China cools, Hainan Drinda looks for relief overseas
002865.SHE -
Sun shines on JinkoSolar, but clouds loom on the horizon
JKS.US 688223.SHG
-
Solar storm takes the shine off JinkoSolar
JKS.US 688223.SHG
